Federal Register / Vol. 72, No. 156 / Tuesday, August 14, 2007 / Notices 45427 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Public Meeting of the President’s 

Council on Bioethics on September 6–

7, 2007 

AGENCY: The President’s Council on 

Bioethics, HHS. 

ACTION: Notice. 

SUMMARY: The President’s Council on 

Bioethics (Edmund D. Pellegrino, MD, 

Chairman) will hold its thirtieth 

meeting, at which it will (1) Discuss a 

projected ‘‘white paper’’ on the 

neurological standard for the 

determination of death; (2) continue the 

exploratory phase of a potential inquiry 

into the ‘‘crisis’’ of the healing 

professions with expert presentations 

and Council discussions; and (3) 

continue the exploratory phase of a 

potential inquiry into ethical issues 

associated with nanotechnology with 

expert presentations and Council 

discussions. Subjects discussed at past 

Council meetings (although not on the 

agenda for the September 2007 meeting) 

include: therapeutic and reproductive 

cloning, assisted reproduction, 

reproductive genetics, the ethics of 

health care, neuroscience, aging 

retardation, organ transplantation, 

newborn screening, human dignity, 

personalized medicine, and lifespanextension. Publications issued by the 

Council to date include: Human Cloning 

and Human Dignity: An Ethical Inquiry 

(July 2002); Beyond Therapy: 

Biotechnolody and the Pursuit of 

Happiness (October 2003); Being 

Human: Readings from the President’s 

Council on Bioethics (December 2003); 

Monitoring Stem Cell Research (January 

2004), Reproduction and Responsibility: 

The Regulation of New Biotechnologies 

(March 2004), Alternative Sources of 

Human Pluripotent Stem Cells: A White 

Paper (May 2005), and Taking Care: 

Ethical Caregiving in Our Aging Society 

(September 2005). Reports on the 

bioethical significance of the concept of 

human dignity and on organ 

procurement, transplantation, and 

allocation are forthcoming. 

DATES: The meeting will take place 

Thursday, September 6, 2007, from 9 am 

to 5:15 pm, ET; and Friday, September 

7, 2007, from 8:30 am to 11:45 am, ET. 

ADDRESSES: The Carolina Inn, 211 

Pittsboro Street, Chapel Hill, NC 27516. 

Phone 919–933–2001 or 1–800–962–

8519. 

Agenda: The meeting agenda will be 

posted at http://www.bioethics.gov. 

Public Comments: The Council 

encourages public input, either in 

person or in writing. At this meeting, 

interested members of the public may 

address the Council, beginning at 11:30 

am, on Friday, September 7. Comments 

are limited to no more than five minutes 

per speaker or organization. As a 

courtesy, please inform Ms. Diane M. 

Gianelli, Director of Communications, 

in advance of your intention to make a 

public statement, and give your name 

and affiliation. To submit a written 

statement, mail or e-mail it to Ms. 

Gianelli at one of the addresses given 

below. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Diane M. Gianelli, Director of 

Communications, The President’s 

Council on Bioethics, 1425 New York 

Avenue, NW., Suite C100 Washington, 

DC 20005. Telephone 202/296–4669. Email info@bioethics.gov. Web site: 

http://www.bioethics.gov. 

Dated: August 6, 2007. 

F. Daniel Davis, 

Executive Director, The President’s Council 

on Bioethics. 

[FR Doc. 07–3948 Filed 8–13–07; 8:45 am] 

BILLING CODE 4154–07–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Misconduct in Science 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI), 

the Assistant Secretary for Health, and 

another Federal agency have taken final 

action in the following case: 

Juan Carlos Jorge-Rivera, Ph.D., 

Dartmouth College: Based on the 

findings of an inquiry conducted by 

Dartmouth College, an investigation 

conducted by another Federal agency, 

and additional analysis conducted by 

the Office of Research Integrity (ORI) 

during its oversight review, the U.S. 

Public Health Service (PHS) found that 

Juan Carlos Jorge-Rivera, Ph.D., former 

postdoctoral fellow, Department of 

Physiology, Dartmouth College, engaged 

in misconduct in science in research 

funded by National Institute of 

Neurological Disorders and Stroke 

(NINDS), National Institutes of Health 

(NIH), grant R01 NS28668. 

Specifically, Dr. Jorge-Rivera 

knowingly and intentionally falsified 

amplifier gain in at least eleven (11) 

experiments of his postdoctoral research 

aimed at measuring the effects of 

anabolic steroids on GABAnergic 

current in brain cells and reported the 

falsified data in Figures 4 and 6 of the 

following paper: Jorge-Rivera, J.C., 

McIntyre, K.L., & Henderson, L.P. 

‘‘Anabolic steroids induce region- and 

subunit-specific modulations of GABA 

receptor mediated currents in the rat 

forebrain.’’ Journal of Neurophysiology 

83:3299–3309, 2000. 

Dr. Jorge-Rivera has been debarred by 

the Federal agency with joint 

jurisdiction for a period of two (2) years, 

beginning on January 11, 2007, and 

ending on January 11, 2009. 

ORI has implemented the following 

administrative actions: 

(1) For a period of three (3) years, 

beginning on June 23, 2007, and ending 

on June 22, 2010, Dr. Jorge-Rivera is 

prohibited from serving in any advisory 

capacity to PHS, including but not 

limited to service on any PHS advisory 

committee, board, and/or peer review 

committee, or as a consultant; and 

(2) for a period of three (3) years, 

beginning at the end of his debarment 

period (January 11, 2009), and ending 

on January 10, 2012, Dr. Jorge-Rivera 

must submit, in conjunction with each 

application for PHS funds, annual 

reports, manuscripts, or abstracts of 

PHS-funded research in which he is 

involved, a certification that the data he 

provides are based on actual 

experiments or are otherwise 

legitimately derived and that the data, 

procedures, and methodology are 

accurately reported in the application or 

report. 

FOR FURTHER INFORMATION CONTACT: 

Director, Division of Investigative 

Oversight, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852, (240) 453–8800. 

Chris B. Pascal, 

Director, Office of Research Integrity. 

[FR Doc. E7–15881 Filed 8–13–07; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–07–0677] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

mstockstill on PROD1PC66 with NOTICES